美瑞健康國際(02327.HK)將額外使用最多6,900萬元進一步購回股份
美瑞健康國際(02327.HK)公佈,截至本月25日,公司已根據股份回購授權行使權力,並據此以約6,900萬元回購了1.54億股股份,公司剩餘未動用的最高總額約3,100萬元。
於本月28日,董事會決定繼續動用股份購回授權,將額外使用最多6,900萬元的資金總額以進一步進行建議股份購回,並視乎市況不定期於公開市場購回股份,故此,董事會已授權但未動用作爲回購股份的資金最高總額合共約1億元。公司將從現有可動用現金儲備及自由現金流量爲購回撥付資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.